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GABAergic inhibition and particularly perisomatic inhibition play a crucial role in controlling the firing properties of large principal
cell populations. Furthermore, GABAergic network is a key element in the therapy attempting to reduce epileptic activity. Here,
we present a review showing the synaptic changes of perisomatic inhibitory neuronal subtypes in the hippocampus of temporal
lobe epileptic patients, including parvalbumin- (PV-) containing and cannabinoid Type 1 (CB1) receptor-expressing (and mainly
cholecystokinin-positive) perisomatic inhibitory cells, known to control hippocampal synchronies.We have examined the synaptic
input of principal cells in the dentate gyrus and Cornu Ammonis region in human control and epileptic hippocampi. Perisomatic
inhibitory terminals establishing symmetric synapses were found to be sprouted in the dentate gyrus. Preservation of perisomatic
input was found in the Cornu Ammonis 1 and Cornu Ammonis 2 regions, as long as pyramidal cells are present. Higher density
of CB1-immunostained terminals was found in the epileptic hippocampus of sclerotic patients, especially in the dentate gyrus. We
concluded that both types of (PV- and GABAergic CB1-containing) perisomatic inhibitory cells are mainly preserved or showed
sprouting in epileptic samples. The enhanced perisomatic inhibitory signaling may increase principal cell synchronization and
contribute to generation of epileptic seizures and interictal spikes.
1. Introduction
Hippocampal interneurons are classified into different func-
tional groups: dendritic, perisomatic, and interneuron-
selective inhibitory cells [1–3].Dendritic interneurons project
their axons to the dendritic region of principal cells and
control their input, while perisomatic interneurons innervate
the axon initial segment and the somatic region (including
proximal dendrites) of principal cells to influence their
output. The third group, the interneuron-selective inhibitory
cells, innervates exclusively other interneurons [4], regulating
the synchrony of hippocampal inhibitory networks [1].
Three main types of perisomatic interneurons can be
distinguished in the human hippocampus: parvalbumin-
(PV-) positive axo-axonic or chandelier cells, PV-positive
basket cells, and Type 1 cannabinoid receptor- (CB1-) pos-
itive basket cells also containing cholecystokinin [5]. The
two neurochemically different basket cell populations have
different role in network oscillations. PV-positive basket cells
are known to be specialized to control rhythms whereas
CB1-positive interneurons influence the fine tuning of hip-
pocampal synchronies [3]. These two basket cell types
are differentiated by their different connectivity, receptors,
neuromodulators, and neurotransmitters [6]. PV-containing
interneurons are mainly innervated by local principal cells
and so are highly efficient in oscillatory functions. In contrast,
CB1-positive basket cells receive large amount of subcortical
inputs carrying information about the “inner world” of
the brain [7] and modulate synchronous ensemble activity
accordingly. Therefore, PV-positive basket cells are thought
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(a) Control (b) Epileptic (mild)
(c) Epileptic (patchy)
(d) Epileptic (sclerotic)
Figure 1: Light micrographs show the distribution of PV-containing interneurons in the human control (a) and epileptic (b–d) CA1 region.
(a) Horizontal PV-positive cells (double arrowheads) are present in the stratum oriens (s. o.). Multipolar PV-positive cells (arrows) located
in the stratum pyramidale (s. p.) send their dendrites to all layers (arrowheads). (b) In the nonsclerotic epileptic CA1 region (Type 1, mild)
the number of PV-positive elements (somata and dendrites) has decreased, mainly visible in the stratum oriens. (c) In the nonsclerotic CA1
region with patchy cell loss (Type 2) the decrease in the number of PV-positive elements is even more pronounced. In several cases, surviving
pyramidal cells (left side) accumulate the chromogene diaminobenzidine (giving aspecific staining), possibly due to cellular degeneration
processes. (d) In the sclerotic CA1 region (Type 3) only a few PV-stained cells and dendrites are present. Scale bar: 50 𝜇m.
to function as “clockworks” for cortical network oscillations,
whereas CB1-expressing interneurons operate as a “plastic
fine-tuning device.” Perisomatic inhibition has an important
role in the generation and regulation of sharp wave-ripples
[8], gamma oscillations [9], and seizure-like activities [10]
in rodent hippocampal slice preparations. The first attempts
have been made to achieve seizure-control via manipulation
of perisomatic inhibition in animal models, by selectively
stimulate PV-positive neurons and by transplanting interneu-
ron precursors [11–13]. However, it is still controversial
whether perisomatic inhibition of the human hippocampus
is increased or decreased during epileptic conditions [11, 14–
16]. Here we summarize the fate of PV-immunostained and
CB1-immunopositive perisomatic inhibitory interneurons in
the hippocampus of temporal lobe epileptic patients. We
show that changes in perisomatic inhibition show a complex
picture, depending on the hippocampal subregion and the
degree of sclerosis.
For these studies we used six control brains from autopsy
subjects with no signs of neurological disorders and 57
hippocampi surgically removed from patients with temporal
lobe epilepsy. The control brains were removed 2 hours
after death; the dissection was performed in the Forensic
Pathology Department of the Semmelweis University Med-
ical School. The study was approved by the ethics committee
at the Regional and Institutional Committee of Science and
Research Ethics of Scientific Council of Health (TUKEB 5-
1/1996, further extended in 2005) and performed in accor-
dance with the Declaration of Helsinki. The fixation method
and the method of the immunocytochemistry are described
in our previous papers [5, 17–20].
2. Results
Temporal lobe epileptic (TLE) patients are usually classified
based on the degree of hippocampal atrophy. There is still no
consensus on the nomenclature of the human hippocampal
subregions. The terms hilus, end folium, CA4, and CA3c
region are all used and designate slightly different and (in
some cases) overlapping areas, all located within the blades
of the dentate granule cell layer [17, 21–26]. The transitional
area between the CA1 region and the subiculum was also
called distal portion of CA1 region in several studies [25, 26]
or prosubiculum in others [18, 23, 27]. However, all research
groups agreed in establishing two main groups: patients
with or without hippocampal sclerosis. Further separation of
the epileptic patients was done either based on granule cell
excitability, etiology, and surgical outcome [28] or based on
complex cell loss pattern [18].The sclerotic hippocampus was
further divided into subgroups, based on the atrophy of the
end folium and the CA1 region [26]. In this review, we will
follow the groups established in [18] (see Figure 1).
Briefly, (I) Type 1 (mild): it is similar to control, with no
considerable principal cell loss in the CA1 region. A slight
loss of certain interneuron types is visible in the stratum
oriens and hilus. (II) Type 2 (patchy): pyramidal cell loss
is in patches in the CA1 region without signs of atrophy.
Interneuron loss ismore pronounced. (III). Type 3 (sclerotic):
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the CA1 region is atrophic and shrunken, the principal cell
loss is almost complete, and the layers cannot be separated.
Interneurons show considerable changes in their distribution
and morphology [20].
2.1. Changes in the Distribution of
Parvalbumin-Containing Interneurons
2.1.1. Control HumanHippocampus. Parvalbumin- (PV-) im-
munoreactivitywas only found in nonprincipal cells through-
out the human hippocampus [24, 29, 30]. PV-positive
interneurons were located in all layers of the dentate gyrus.
They were the most abundant in the hilus and less in
the stratum moleculare, and only several cells were visible
in the granule cell layer. The majority of the cells were
multipolar, but some of them had triangular or fusiform
shape.Throughout Ammons’s horn PV-positive interneurons
were located within or close to the pyramidal cell layer
(Figures 1 and 2). They usually displayed large cell body,
long smooth dendrites running across all layers. Another
characteristic cell type was the fusiform cell with horizontal
dendrites found in the stratumoriens (Figure 1(a)).The axons
formed a homogenous network in the principal cell layers in
both the dentate gyrus and Ammon’s horn (Figure 2(a)).
2.1.2. Hippocampi of Temporal Lobe Epileptic Patients. In the
epileptic human hippocampus PV-immunoreactivity has de-
creased to different degree (Figure 1), in correlation with the
extent of the severity of the hippocampal sclerosis [17, 18, 24,
25]. The PV-positive neuronal densities determined by the
different research groups could be hardly compared because
of the differences in the nomenclature of the hippocampus
and in the quantification methods. However, the trends were
similar: a moderate decrease was found in the number of PV-
positive interneurons in the dentate gyrus, the CA1, CA2, and
CA3 regions of patients with no sclerosis [17, 25].The number
of PV-positive neurons was the closest to control values (∼
75% of the control in the dentate gyrus and ∼60% in the
CA1 region) in themild group (Type 1) and further decreased
(to ∼20% of the control in both the dentate gyrus and the
CA1 region) in the patchy group (Type 2, Figures 1(b) and
1(c), [18]). In the sclerotic hippocampus (Type 3), the number
of PV-positive cells has dramatically decreased, in both the
dentate gyrus (to 6% of the control) and the CA1 region (to
21% of control, [17, 18, 25]). Data from Andrioli et al. [25]
showed similar trends, although they used different nomen-
clature to determine the hippocampal subregions.They found
significant decrease in the density of PV-positive cells in
the nonsclerotic hippocampus only in the polymorphic layer
of the dentate gyrus (part of the hilus in our studies) and
the CA2 region (both ∼50% of control). The density of PV-
positive cells was ∼65% of the control in the CA3 and ∼75%
in the CA1 region. The transitional zone between the CA1
region and the subiculum was comprised in the CA1, which
we excluded and called prosubiculum. For this reason, they
found a reduction of only∼35% in the sclerotic CA1 region, in
contrast to our reduction of 79%.They observed PV-positive
cell densities ∼20% of the control in the polymorphic layer
of the dentate gyrus, ∼25% in the CA3, and ∼50 in the CA2
regions. The cells located in the hilus of the dentate gyrus
and the horizontal cells of the stratum oriens in the Cornu
Ammonis were the most sensitive to epileptic injury. Their
numbers reduced more than that of neurons in other layers
[17, 18]. In the mild group, hilar PV-stained cell density was
∼50% of the control (which corresponds to the polymorphic
layer in [25]), ∼13% in the patchy group, and 0.6% in the
sclerotic hippocampi.The subiculum is usually considered as
a resistant region of the hippocampal formation to epileptic
injury. However, the number of PV-containing interneurons
has significantly decreased in both the nonsclerotic and
sclerotic epileptic samples [25]. Furthermore, the anomalous
appearance of the calcium binding protein calbindin (usually
present in dendritic inhibitory interneurons, see [1]) has been
observed in subicular axo-axonic cell terminals [15, 31]. The
existence of a small subgroup of chandelier cells was though
demonstrated in the human control and epileptic CA1 region
[32].
The distribution of PV-stained fibers has also changed
in epilepsy (Figures 3(a)–3(d)). In Type 1 nonsclerotic hip-
pocampus the PV-positive axonal network had a similar if not
higher density than that of controls [18]. The complexity and
the density of chandelier cell axonal formations (Figures 2(a)
and 3(a)–3(c)) were also shown to be considerably increased
[15]. In all other epileptic cases (patchy and sclerotic groups),
the axonal cloud was found to become inhomogeneous (Fig-
ures 2(b) and 3). Patches of dense axonal network alternated
with areas lacking immunostained elements in the dentate
granule cell layer (Figure 2(b), [15, 17–19]).Despite the general
reduction of PV-immunostaining, some PV-positive basket
and chandelier formations remained both in the dentate
gyrus and the Cornu Ammonis regions (Figure 3), which
were considerablymore complex, than in the control [15]. PV-
stained fibers could be hardly seen within the regions with
severe principal cell loss (the sclerotic CA1 region and the
CA3c/hilar region; see Figure 3(d)), although the presence
of very few PV-positive cell bodies and dendrites was shown
[15, 18]. In the transition zone between the sclerotic CA1
and subiculum (also called prosubiculum) hypertrophic, very
complex PV-stained basket formations were observed [31].
Electron Microscopy of PV-Containing Synapses
(1) Control. PV-positive somata showed the characteristic fea-
tures of interneurons at electron microscopic level [30]. They
displayed nuclear infolding, intranuclear rods and sheets,
large cytoplasm containing numerous organelles, and lipo-
fuscin granules.They received both symmetrical (inhibitory)
and asymmetrical (excitatory) axosomatic synapses. The
dendrites were usually smooth and received large numbers
of asymmetrical synapses [30].
PV-positive axon terminals formed symmetrical synapses
with mainly principal cell somata, proximal dendrites, and
axon initial segments (AISs, Figures 3(e)–3(h)). The distri-
bution of the target elements of PV-axon terminals showed
some differences between the dentate gyrus [17] and the CA1
region [18] of the human epileptic hippocampus. Granule
cell somata were more frequently innervated by PV-positive
axon terminals than CA1 pyramidal cell bodies, whereas
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(g) Epileptic
Figure 2: Camera lucida drawings show PV-positive interneuron with its axonal cloud (a) and the inhomogeneous axonal staining (b) in
the human sclerotic (Type 3) dentate gyrus. Insert on (a) shows the complex chandelier formations in the dentate gyrus of the sclerotic
hippocampus. (b) Dense PV-positive axonal patches are alternated with lack of stained boutons in the granule cell layer of epileptic patients.
Schematic cell bodies indicate the location of PV-positive interneuron somata in the stratum moleculare. s. m.: stratum moleculare, s. g.:
stratum granulosum, and h: hilus. Perisomatic inhibitory input included PV-positive (c) and PV-negative (d) symmetrical (presumably
inhibitory) synapses both in the human control and in epileptic dentate gyrus (arrows). In the sclerotic hippocampus, mossy fibers were
also found to form asymmetrical (presumably excitatory) synapses on granule cell somata ((e), arrowhead). Electron micrographs of PV-
negative (f) and PV-positive (g) inhibitory synapses terminating on AISs, in the control and epileptic dentate gyrus, respectively. Note the
larger bouton in the epileptic tissue, giving a perforated synapse. The somatic and axonal inhibitory synaptic coverage were found to be
increased in all epileptic samples. PV+: parvalbumin-positive, PV−: parvalbumin-negative, MF: mossy fiber, and AIS: axon initial segment.
Scale bars: (a) 20𝜇m, insert: 15 𝜇m, (b) 100 𝜇m, and (c–g) 1 𝜇m.
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(a) Control (b) Epileptic (mild) (c) Epileptic (patchy) (d) Epileptic (Sclerotic)
(e) Control (CA2) (f) Epileptic (CA2) (g) Control (CA1) (h) Epileptic (CA1)
Figure 3: High magnification light micrographs (a–d) show the somata (upper panels) and the axonal cloud (lower panels) of PV-positive
cells in the human control (a) and epileptic (b–d) CA1 region. The number of PV-positive elements decreased with the degree of cell loss
in the human epileptic CA1 region. PV-stained axons (lower panels) formed a dense network in the stratum pyramidale of the CA1 region
as long as their postsynaptic targets, that is, pyramidal cells, are present (b, c). Note the basket-like formation on (a)–(c) (arrowheads) and
chandelier-like formation on (b) (double arrowheads). In the sclerotic CA1 region lacking principal cells hardly any PV-positive axons can be
seen (d). Scale bar: (a–d) 20𝜇m. Electronmicrographs show PV-stained axonal boutons contacting pyramidal cell somata (e, f) in the control
(e) and epileptic (f) CA2 region. Axon initial segments (AISs, (g) and (h)) were the other main targets of PV-positive axons in the human
control (g) and epileptic (h) CA1 region. Scale bars: (a)–(d) 20 𝜇m; (e)–(h) 1 𝜇m.
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Table 1: Distribution of the target elements of PV-positive terminals (%). Changes in the target elements of PV-positive terminals were
determined in human control and epileptic dentate gyrus and CA1 region by examining 42 to 107 boutons per patient per region. Percentages
were formed for each control subject and epileptic patient and were then averaged. Note that relatively high ratio of PV-positive boutons
terminated on other cellular compartments compared to the perisomatic region (i.e., large numbers of terminals gave synapses to dendrites
and spines).
Number of boutons
examined (number of
subjects or patients)
Soma
(%) Dendrite (%)
Axon initial segment
(%)
Spine
(%)
DG Control 105 (2) 32.6 ± 3.0 44.3 ± 4.9 15.9 ± 5.2 7.2 ± 7.1
Epileptic 213 (4) 14.5 ± 9.0 45.4 ± 8.8 31.3 ± 9.9 8.8 ± 5.8
CA1 region Control 215 (4) 14.8 ± 6.9 53.1 ± 6.2 14.5 ± 8.0 17.6 ± 8.0
Epileptic 275 (4) 11.1 ± 4.6 60.8 ± 7.5 17.3 ± 9.6 10.9 ± 6.7
the proportion of PV-stained boutons innervating AISs of
granule and CA1 pyramidal cells was similar (Table 1). Lower
ratio of PV-immunopositive terminals contacted dendrites
and spines in the dentate gyrus than in the CA1 region
(Table 1).
(2) Epileptic. PV-positive cell bodies and dendrites were
examined at electron microscopic level in the epileptic
dentate gyrus and CA1 region.The subcellular characteristics
of PV-stained cells remained unchanged in the epileptic
tissue. The input characteristics, that is, the large amount
of asymmetrical synaptic input, were found to be similar to
control. However, sprouted mossy terminals were found to
terminate on PV-positive cells in the stratum moleculare of
the dentate gyrus. Furthermore, PV-positive dendrites were
partly covered by glial elements in the sclerotic CA1 region
[18].
The target selection of PV-positive axons has been slightly
modified in epilepsy. Dentate granule cell somata were
contacted in a lower AIS contacted by a higher ratio than
in the control (Table 1, [17]). The target distribution did
not change systematically in the epileptic CA1 region. High
variability was found between the different subjects of all
groups (control and epileptic with mild and patchy cell loss,
[18]).
(3) Somatic Input of Hippocampal Principal Cells. Another
approach was used to determine the perisomatic inhibitory
innervation of principal cells of the human hippocampus.
Measuring the soma/AIS perimeter and the length of active
zones of all inhibitory synapses they received helped us
to determine the synaptic coverage. This is an estimate of
somatic inhibition that does not depend on the PV-content
of presynaptic terminals (for the exact method see [17, 18])
andmeasures all inhibitory synaptic inputs coming fromboth
(PV+ and CB1+) basket cell populations. Briefly, we analyzed
about 30 to 50 neighboring principal cell somata or AISs
in one electron microscopic section. The perimeter of the
somata and AISs, as well as the synaptic length of all boutons
contacting them, was measured. The synaptic coverage was
provided as 𝜇m of synaptic length/100 𝜇m of soma or AIS
perimeter. Parvalbumin-immunoreactivitywas shown to dis-
appear from surviving inhibitory interneurons in an animal
model of epilepsy [33–35]. The inhibitory synaptic coverage
includes inhibition coming from perisomatic inhibitory cells
as well, which lost their PV-immunoreactivity.
The number of somatic inhibitory synapses contacting
dentate granule cells has increased in epilepsy to about 125–
135% of control values [17]. The ratio of PV-positive boutons
innervating granule cell bodies decreased to about two-
thirds in the mild and to about one-third in the patchy
and sclerotic epileptic group (Table 2). When measuring the
synaptic coverage of granule cell somata, we also received
an increase to 126–134% of control value (Table 2). The
synaptic coverage of granule cell AISs has increased to a larger
extent, than somatic inhibitory input: 215–525%of the control
(Table 2, [32]). The ratio of PV-positive boutons contacting
AISs has been unchanged in the nonsclerotic groups and
was enhanced in the sclerotic hippocampus (Table 2), in
accordance with the presence of more complex chandelier
formations [15]. We should note that large differences were
observed in the ratio of PV-positive boutons contacting
AISs between patches containing dense (48.1%) and poor
(7.9%) PV-positive fiber network. In the patches lacking PV-
containing axonal clouds granule cells were healthy and the
synaptic coverage of their AISs was similarly enhanced, than
in the patches with strong PV axonal staining.
The somatic input of CA1 pyramidal cells has been
investigated only in the control and the nonsclerotic epileptic
groups (Table 2, [18]), since pyramidal cells could be hardly
found in the sclerotic CA1 region. The somatic synaptic
coverage was unchanged in themild group (Type 1), while the
axonal input—in accordance with the presence of very com-
plex chandelier formations [15]—was found to be increased.
In the nonsclerotic hippocampus with patchy cell loss (Type
2) both the somatic and axonal inhibitory inputs decreased.
We examined patches with and without visible pyramidal
cells at electron microscopic level and found that pyramidal
cells are present in both regions. They looked healthy in
patches containing pyramidal cells, while most of them
showed the signs of severe degeneration and cell death in
the patches lacking pyramidal cells [18]. PV-positive axonal
cloud was present in both types of patches. The ratio of PV-
positive boutons was very high in the CA1 region (23 to
45%) compared to the dentate gyrus (11-12%) and increased
or remained unchanged in the epileptic samples (39 to 47%).
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Changes in the synaptic coverage and in the ratio of PV-
positive boutons innervating CA1 pyramidal cell AISs were
not significant in epileptic tissue [18].
In the dentate gyrus and the CA1 and CA2 regions
numerous symmetrical, presumably inhibitory boutons ter-
minated on principal cell bodies. Asymmetrical, presumably
excitatory synapses innervating principal cell somata were
only seen in the epileptic dentate gyrus with sclerotic hip-
pocampus (Table 2, [17]). Unexpectedly, we also observed
frequent contacts on CA2 pyramidal cell bodies made by
asymmetrical synapses [19], showing the characteristics of
mossy terminals [36]. Therefore, both inhibitory synaptic
coverage and excitatory synaptic coverage have been deter-
mined for CA2 pyramidal cells (Table 2, Figure 3, [19]). In
the epileptic CA2 region the inhibitory synaptic coverage
remained unchanged; however, the ratio of PV-positive axon
terminals contacting pyramidal cell bodies has dramatically
decreased (from 17.5% in control to an average of 2.1% in
epileptic tissue). Excitatory synaptic coverage was about the
half of inhibitory synaptic coverage in the epileptic cases, with
asymmetrical synapses detected on the somaof 50–70%of the
examined CA2 pyramidal cells [19].
Inhibitory synaptic coverage of CA2 pyramidal cells
exceeded that of CA1 pyramidal cells, which was slightly
higher than that of dentate granule cells in the control
hippocampus (0.80±0.41 versus 0.64±0.47 versus 0.53±0.64).
The inhibitory synaptic coverage of CA1 pyramidal cell AISs
was outstandingly high, compared to the somatic and granule
cell AIS synaptic coverage (2.34 ± 2.55 versus values of 0.5 to
0.8). The ratio of PV-positive axon terminals innervating the
perisomatic region of principal cells was the highest in the
CA1 region, compared to other regions of the hippocampus
(Table 2, Figures 2 and 3).
In summary, inhibitory input of granule cell somata and
AISs was enhanced in the epileptic hippocampus, together
with an increase of chandelier formation complexity. Peri-
somatic inhibitory input is present in the Cornu Ammonis
regions as long as pyramidal cells survive. There are though
regional differences: the ratio of PV-positive terminals was
increased or unchanged in the epileptic CA1 region, while
it was dramatically dropped in the CA2 region. We could
observe the sprouting of mossy fibers in both the epileptic
dentate gyrus and CA2 region. They terminated on the
somatic membrane of principal cells in the sclerotic hip-
pocampus, which was never seen in the control tissue [19].
2.2. Changes in the Fiber Density of CB1-Immunostained
Interneurons. Majority of cannabinoid receptor Type 1- (CB1-)
immunostained interneurons were shown to contain the
neurochemical marker cholecystokinin (CCK) in the human
hippocampus [5, 37]. Most of them are basket cells and
terminate on proximal dendrites or cell bodies of principal
cells. They can be found in all subfields of the control
human hippocampus and dentate gyrus [5]. Unlike PV-
positive basket cells, CB1-immunostained cells are present
in all fields of the hippocampi of epileptic patients; they
can be observed even in the sclerotic CA1 region [38]. This
outstanding preservation of CB1-expressing cholecystokinin-
immunoreactive cells [20] in epilepsy is comparable to the
surviving of calbindin-positive interneurons [32, 39]. CB1 is
present on both excitatory and inhibitory terminals [3, 40,
41]. In the present review we have examined only the fate of
CB1 receptor-expressing GABAergic cells.
The downregulation of the overall CB1 mRNA (including
receptors to be transported to both excitatory and inhibitory
synaptic terminals) has been described in the human epilep-
tic hippocampus [38]. Expression of the endocannabinoid
molecules (together with CB1 receptor) linked to excitatory
network was demonstrated to be decreased, but no reduction
of the CB1 receptor associated with inhibitory interneu-
rons could be shown [38]. Different antibodies against CB1
recognize different parts of the receptor and give different
immunostaining patterns. One antibody stains all CB1 recep-
tors, present in both excitatory and inhibitory terminals,
whereas the other—used in our previous studies—detects
CB1 receptor located exclusively on inhibitory terminals [5,
20]. The present review was based on the studies using
the latter antibody visualizing CB1 receptors expressed by
GABAergic interneurons.
The distribution of synaptic targets of CB1-immuno-
positive elements was studied in the stratum moleculare of
the dentate gyrus in control and sclerotic TLE subjects, where
the highest fiber density was present.The postsynaptic targets
of CB1-immunopositive terminals were mostly dendrites, cell
bodies, and spines, and their ratio was similar in control and
epileptic subjects [20]; about two-thirds of the CB1-labeled
axons terminated on dendrites, ∼14% on cell bodies, and ∼
13% on spines.
In the nonsclerotic epileptic hippocampi, the distribution
of CB1 receptors in the dentate gyrus did not differ signif-
icantly from the normal postmortem controls. In contrast,
in the dentate gyrus of epileptic patients with sclerotic CA1
region a strong increase in CB1-immunostaining was demon-
strated [20]. The density of immunostained fibers increased
in the dentate molecular layer (Figure 4) and became inho-
mogeneous in the hilus forming densemeshwork of terminals
around the surviving mossy cells.The density of CB1-positive
fibers establishing symmetric synapses was measured by
confocal laser scanningmicroscope, and the elevation of CB1-
R-immunostaining was 1,5-fold of the control [20].
The origin of this density increase could be both the
elevated number of receptors and sprouting of CB1-R express-
ing fibers. The sprouting of the axons of a perisomatic
inhibitory interneuron type, the PV-containing axo-axonic
cells, has been observed in the human epileptic dentate
gyrus. However, the increase in the number of receptors
in individual terminals cannot be excluded either. Accurate
quantification of the receptor amount and fiber density was
investigated in a pilocarpine model of TLE in mice, where
both the density of fibers and the number of CB1 receptors
were shown to be increased in the dentate gyrus of sclerotic
hippocampi, but only in inhibitory terminals establishing
symmetric synapses [42].
Changes of the CB1 receptor-expressing fibers of other
regions of the human hippocampuswere not examined quan-
titatively in epilepsy. The qualitative light microscopic obser-
vation however showed similar changes in the CA3 region
of both sclerotic and nonsclerotic hippocampi (Figure 5) to
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(c) Control (d) Epileptic
Figure 4: Light micrographs show the distribution of CB1-immunoreactive elements in the human control (a, c) and epileptic (b–d) dentate
gyrus. (a) Dense CB1-immunopositivemeshwork was present around the dentate granule cells and in the stratummoleculare (s. m.).The hilus
(H) contained less CB1-positive terminals. Arrow points to a CB1-positive interneuron. (b) In epileptic patients with hippocampal sclerosis
the density of CB1-positive fibers has been increased in the stratummoleculare and granulosum. Note the dispersion of granule cells. Arrows
point to CB1-positive interneurons. (c) CB1-immunostained terminals were present in the hilus, in homogenous distribution. Arrow points
to a CB1-positive interneuron. (d) In the hilus of the epileptic hippocampus more CB1-positive terminals were present; they often formed
dense network around surviving mossy cells or interneurons (arrowheads).
those we found in the dentate gyrus. The homogenous fiber
network has been enhanced and became inhomogeneous in
the stratum pyramidale and formed extremely strong mesh-
work around individual cells (Figure 5(c)). Similar extensive
networks were found around individual mossy cells in the
hilus of the dentate gyrus (Figure 4(d)). The nonsclerotic
CA1 region displayed similar density and distribution of CB1-
positive fibers (Figure 6); however, in Type 2 patchy samples
inhomogeneous fiber density was also observed.The sclerotic
CA1 region still contained scattered CB1-immunopositive
fibers (Figure 6(c)). In the lack of electron microscopic
examination, the synaptic targets and function of these CB1
fiber networks have not been determined.
3. Conclusion
Our results show that both PV-containing and CB1-
expressing perisomatic inhibitory cells are preserved in the
epileptic hippocampi.
Although the number of PV-positive cells has been
decreased in parallel with the degree of sclerosis, their axon
terminals were present and even sprouted in the dentate
gyrus, innervating larger numbers of granule cell somata and
axon initial segments, than in the control. The presence of
hypercomplex basket and chandelier axonal formations in
the epileptic hippocampus also supports the sprouting of
perisomatic axons [15, 31]. In the CA1 and CA2 regions PV-
immunoreactive cells and their axons survive as long as their
postsynaptic targets, the pyramidal cells, are present; they
are missing exclusively in the sclerotic CA1 region. Somatic
and axonal inhibitory input also remained unchanged (or
slightly sprouted) in the epileptic CA1 and CA2 regions with
surviving pyramidal cells. However, regional differences can
be seen in the ratio of PV-positive axon terminals contacting
principal cells in the hippocampus: 23 to 45%of the inhibitory
boutons are PV-stained in the CA1 region, whereas only 18%
in the CA2 region and 11 to 12% are PV-stained in the dentate
gyrus.
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(a) (b) (c)
Figure 5: Light micrographs show the distribution of CB1-immunopositive fibers in the human control (a) and epileptic (b-c) CA3 regions.
(a) Homogeneous CB1-immunopositive meshwork was present around the pyramidal cells. (b) In epileptic patients without hippocampal
sclerosis the density of CB1-positive fibers has been increasedmoderately. (c) Further increase in density has been observed in the CA3 region
of the sclerotic hippocampi, if pyramidal cells were preserved. Arrows point to pyramidal cell bodies surrounded by basket-like formations
of CB1-positive fibers. Scale bar: 20 𝜇m.
(a) (b) (c)
Figure 6: Light micrographs show the distribution of CB1-immunopositive fibers in the human control (a) and epileptic (b-c) CA1 regions.
(a) CB1-immunopositive axonal network was present in the stratum pyramidale. (b) In epileptic patients without hippocampal sclerosis the
density of CB1-positive fibers has been slightly increased. (c)The density of CB1-positive axons has been decreased in the sclerotic CA1 region.
Arrows point to pyramidal cell bodies surrounded by basket-like formations of CB1-positive fibers. Arrowheads show axons. Scale bar: 25 𝜇m.
The decrease in PV-positive cell numbers has been shown
in animal models of epilepsy [33–35, 43]. The calcium over-
load of the cells—resulting in conformal changes of the par-
valbuminmolecule—was supposed to be the cause of reduced
immunoreactivity in animals [34, 35]. Our electron micro-
scopic results indicate that similarmechanismsmight operate
in the human epileptic hippocampus; that is, the reduction
of PV-positive elements in epilepsy is likely due to lack of
PV-immunostaining rather than to interneuronal cell death.
CB1-R-expressing fibers were also shown to be sprouted in all
subfields of the epileptic hippocampus, except the sclerotic
CA1 region. However, the CB1-R-immunostained cells and
fibers are present even in this region of the sclerotic patients,
showing remarkable preservation of this cholecystokinin-
containing perisomatic inhibitory cell type.
Although inhibitory input of principal cells was preserved
in the human epileptic hippocampus [17–19], this does
not imply that perisomatic inhibition remained unchanged.
Changes inGABA-A receptor subunits in the human epileptic
hippocampus [44, 45] suggested perturbations in GABAergic
signaling at the subcellular levels, with possible functional
consequences for perisomatic inhibition. Electrophysiologi-
cal recordings in the human epileptic hippocampal formation
confirmed that inhibition is altered in human epilepsy.
Impaired inhibitionwas found in the dentate gyrus in parallel
with mossy fiber sprouting [46, 47], and weak or absent inhi-
bitionwas found in theCA2 region in one study [48], whereas
functional but modified inhibition was found in another
paper [19]. Furthermore, depolarizing and hyperpolarizing
inhibitory synaptic potentials were found in the subiculum
[49, 50], contributing to the generation of interictal activity
in vitro.
Different types of interneurons show different vulnerabil-
ity to epileptic injury. Calbindin-positive dendritic inhibitory
cells are considered as one of the most resistant cell types in
epilepsy [24, 32, 39]. Numerous calbindin-stained interneu-
rons were found throughout the epileptic hippocampus,
including the sclerotic CA1 region as well (lacking pyra-
midal cells), and were shown to change their postsynap-
tic targets from principal cells to surviving interneurons,
including themselves [32]. The considerable sensitivity of the
somatostatin and neuropeptide Y-immunostained dendritic
inhibitory cells was the first description of the selective
vulnerability of specific interneuron types [51–53]. These
neurons are mainly located in the dentate hilus and the
stratumoriens of the CornuAmmonis and almost exclusively
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overlap with HIPP and O-LM cells [1]. Later, the calretinin-
containing interneuron-specific inhibitory cell type was also
shown to be very sensitive in human temporal lobe epilepsy
[54]. Regarding our results, we can conclude that perisomatic
inhibitory cells are less vulnerable to epilepsy, particularly
in the dentate gyrus, where both basket and chandelier
cell axons were demonstrated to be considerably sprouted.
However, we have to note that PV-positive interneurons are
heterogeneous in point of view of vulnerability to epileptic
injury. Neurons located in the hilus and in the stratum oriens
of the CA1 region (note the same location as somatostatin-
positive interneurons) were found to disappear from the
nonsclerotic epileptic hippocampus as well (Types 1 and 2).
Although the overall density of PV-immunopositive cells
decreased in the epileptic hippocampus [17, 18, 25], the
perisomatic inhibitory input analysis of the principal cells at
electron microscopic level suggested that these cells survived
as long as their postsynaptic targets, that is, the principal cells,
are present, but they lost their PV-immunopositivity [17–19].
The preservation of perisomatic inhibitory cells might be a
compensatory mechanism in epilepsy, to increase the control
of firing activity of principal cells [12]. However, the increased
amount of perisomatic inhibitory input together with func-
tional modifications of GABAergic inhibitory processes may
explain that TLE patients are frequently therapy resistant
[55]. The most often applied antiepileptic drugs target the
GABAergic system and try to enhance it [11]. Perisomatic
inhibitory input has been already enhanced in these patients
and further enhancement of the GABAergic inhibition rather
increases the possibility of epileptic discharges than decreases
it, since perisomatic inhibition is responsible for the syn-
chronous firing of the cells [3].
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